The plants by Daniel Rolander (c. 1723-1793) in Diarium Surinamicum (1754-1765) and herbaria

The manuscripts of Diarium Surinamicum by Daniel Rolander practically remained ignored and unpublished for over 240 years, till the recent publication of its translation into English, which occurred in 2008. In this, the names of species described and/or cited by Rolander were faithfully retained, hence preserving the indication of them without authorship, for the vast majority. In the present work, all the names of plants that were treated by Rolander in his journal, about 664, including by tradition the fungi and algae, are contextualised in relation to the authorship, reference to the publication of the protologue, pagination of citations/descriptions in the manuscripts and in the published translation, indication of probable misidentifications with possible alternative names, vernacular names, and related literature. Additionally, we searched for the vouchers collected by Rolander, scattered in several herbaria, which have been linked to the probable names and descriptions in the diary. Given the considerable time till the publication of these names, and by the lack of indication of their nomenclatural types in the English version, the great majority of the new species described by Rolander, which would have priority if published in due time, became invalid names according to the ICN. Nevertheless, the list of Rolandrian species here presented, from his work that has finally taken a place in the history of natural sciences, shows that he was also a competent botanist, besides being a skilled entomologist, having recognised and detailedly described many of the Surinamese plants hitherto unknown to science.

As (des)ilusões do (ir)real na ficção de Murilo Rubião

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Levantamento qualitativo da avifauna do Campus de Rubião Junior, Unesp/Botucatu-SP

As aves apresentam diversas características que as tornam peças importantes tanto para a educação ambiental, quanto nas tentativas de conservação de habitats. Para isso, levantamentos da composição da avifauna são fundamentais. Assim, realizou-se o levantamento qualitativo das aves que frequentam os espaços de maior circulação de pessoas do Campus de Rubião Junior, UNESP/Botucatu-SP, entre os meses de Março e Outubro de 2009. Adotou-se o método de transectos lineares, através do qual se percorreu dois trajetos distintos, nos horários de maior atividade das aves. As observações foram feitas com o auxílio de binóculos, além de algumas espécies terem sido registradas visual e/ou sonoramente por câmera fotográfica e gravador. Para a identificação das espécies, utilizou-se basicamente guias de campo. Além da lista de espécies, foi possível também calcular as frequências de ocorrência delas. Foram detectadas 67 espécies, distribuídas em 26 famílias, sendo Tyrannidae a mais representativa (15 espécies). O percurso 1 apresentou 13 espécies exclusivas, enquanto o percurso 2, apenas 4. A maioria das espécies (36) apresentou frequência de ocorrência total inferior a 25% e apenas 12 puderam ser consideradas residentes, com frequência de ocorrência total igual ou superior a 75%. Dentre as famílias com mais de um representante, Columbidae apresentou a maior proporção de número de espécies com alta frequência de ocorrência total (> 50%). Os resultados revelaram maior riqueza de espécies na área com maior diversidade de habitats e menor fluxo de pessoas

Levantamento da mastofauna e identificação das influências antrópicas em dois fragmentos de Mata Atlântica transição com Cerrado de Rubião Junior – Botucatu - SP

Atlantic Forest and Cerrado are between the biological richest areas in the world, for that are considered top conservation priorities. Those ecosystems are found at Botucatu region, where it´s extremely fragmented by routes, agricultural areas and urban centres. This fragmentation causes restrictions on animals populations, in particular to medium and large mammals, that needs larger areas to live and also are often hunted. Even isolated and suffering anthropic influences the fragments are fundamental for local biodiversity conservation. We realized a mammal survey on two forest fragments of Atlantic forest transition to Cerrado of Rubião Júnior – Botucatu – SP – Brazil: Santo Antônio Church and Parque das Cascatas forests. The Santo Antônio church munt is considered a turistic point and its forest receive many visitants, Parque das Cascatas forest is inside of a residential condominium. Both areas are classify as semidecidual stational forest and are disconected by Domingos Sartori route, that connect Botucatu centre to Rubião Júnior district. Around both fragments can be found residences, plantations and pastures. The utilized method included: recognition of tracks on the forests, interviews with next residents and sand plots mounting. The interviews indicated 29 mammals species, and 19 was validated for animal traces, overruns or visualization. Other 3 species found were not mentioned on interviews. Totally, was found 22 small and medium mammals presence evidences on both forest fragments. Parque das Cascatas forest showed more diversity (19) then Santo Antônio Church forest (11), and species like Eira barbara, Procyon cancrivorus, Mazama americana, Shiggurus villosus, Dasypus novemcinctus, Didelphis albiventris, Lutreolina crassicaudata and Lepus europaeus looked for other areas once that was verifyed overruns of individuals... (Complete abstract click electronic access below)

Cumulative long-term safety, efficacy and patient-reported outcomes in children with juvenile idiopathic arthritis treated with intravenous abatacept: up to 7 years of treatment

The long-term efficacy and safety of intravenous abatacept in patients (pts) with juvenile idiopathic arthritis (JIA) have been reported previously from the Phase III AWAKEN trial ([1, 2]). Here, we report efficacy, safety and pt-reported outcomes from the open-label, long-term extension (LTE) of AWAKEN, with up to 7 years of follow-up. Pts entered the LTE if they were JIA ACR 30 non-responders (NR) at the end of the 4-month lead-in period (abatacept only), or if they received abatacept or placebo (pbo) in the 6-month double-blind (DB) period. The Child Health Questionnaire was used to evaluate health-related quality of life (HRQoL); physical (PhS) and psychosocial (PsS) summary and pain scores were analyzed. Pain was assessed by parent global assessment using a 100 mm visual analog scale. Efficacy and HRQoL evaluations are reported up to Day 1765 (~ Year 5.5). Safety is presented for the cumulative period (lead-in, DB and LTE), for all pts who received abatacept during the LTE. Of the 153 pts entering the LTE (58 from DB abatacept group, 59 from DB pbo group, 36 NR), 69 completed the trial (29 abatacept, 27 pbo, 13 NR). For pts treated in the LTE, mean (range) exposure to abatacept was 53.6 (5.6–85.6) months. During the LTE, incidence rates of AEs and serious AEs per 100 pt-years were 209.1 and 5.6. Thirty pts (19.6%) had serious AEs; most were unrelated and were musculoskeletal (8.5%) or infectious events (6.5%). No malignancy was reported. There was one death (accidental; unrelated). At Day 169, JIA ACR 50 and 70 response rates were 79.3% and 55.2% in the abatacept group, and 52.5% and 30.5% in the pbo group; 31.0% and 10.2% of pts in the abatacept and pbo groups, respectively, had inactive disease. By Day 1765, JIA ACR 50 and 70 response rates were 93.9% and 78.8% in the abatacept group, and 80.0% and 63.3% in the pbo group; 51.5% and 33.3% had inactive disease. In the NR group, 69.2% and 53.8% of pts achieved JIA ACR 50 and 70 responses at Day 1765, and 30.8% had inactive disease. In pts who entered the LTE, mean baseline PhS scores were below the range for healthy children (abatacept 30.2, pbo 31.0, NR 29.5). At Day 169, 38.3% of pts had reached a PhS score >50 ((1). By the end of the LTE, 43.5% of pts had reached a PhS score >50. At baseline, mean PsS scores for those who entered the LTE were slightly lower than the mean for healthy children (abatacept 43.5, pbo 44.2, NR 47.0). At Day 169, 54.9% of pts had a PsS score >50 (1). By Day 1765, 58.1% of pts had reached a PsS score >50. At baseline, the mean pain score was 42.9. By Day 169, 13.9% of pts were considered pain free (pain score = 0); this was maintained over the LTE (1).